Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,096 | 26,634 | 55,303 | 51,424 | 76,134 |
| Marketable Securities | 8,252 | 7,501 | 0 | 67,680 | 84,468 |
| Receivables | 1,027 | 4,641 | 2,341 | 6,817 | 23,889 |
| Other current assets | 1,702 | 467 | 0 | 0 | 0 |
| TOTAL | $26,315 | $40,376 | $59,128 | $128,919 | $190,681 |
| Non-Current Assets | |||||
| PPE Net | N/A | 23 | 11,295 | 14,140 | 12,867 |
| Other Non-Current Assets | 970 | 143 | 239 | 3,287 | 3,921 |
| TOTAL | $970 | $166 | $11,534 | $17,427 | $16,788 |
| Total Assets | $27,285 | $40,542 | $70,662 | $146,346 | $207,469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,186 | 1,425 | 3,245 | 4,238 | 10,628 |
| Accrued Expenses | 5,529 | 1,966 | 14,282 | 13,263 | 19,543 |
| Other current liabilities | N/A | 6,140 | N/A | 1,238 | N/A |
| TOTAL | $10,349 | $12,398 | $40,355 | $31,408 | $39,130 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,879 | 7,418 | 8,930 | 8,822 | 19,228 |
| Deferred Revenues | 510 | 814 | 11,106 | 2,286 | 2,150 |
| Other Non-Current Liabilities | 5,283 | 618 | 540 | 0 | 1,238 |
| TOTAL | $18,859 | $10,917 | $9,701 | $45,000 | $49,401 |
| Total Liabilities | $29,208 | $23,315 | $50,056 | $76,408 | $88,531 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,586 | 5,818 | 5,214 | 5,179 | 5,184 |
| Common Shares | 76 | 58 | 52 | 52 | 44 |
| Retained earnings | -521,916 | -495,029 | -480,028 | -427,289 | -320,260 |
| Other shareholders' equity | 6 | -3 | 0 | -2 | -19 |
| TOTAL | $-1,923 | $17,227 | $20,606 | $69,938 | $118,938 |
| Total Liabilities And Equity | $27,285 | $40,542 | $70,662 | $146,346 | $207,469 |